Company Analysis

Ping An Biomedical Co., Ltd. (PASW)

Nasdaq: PASW · Apparel & Other Finishd Prods of Fabrics & Similar Matl · filing with the SEC since 2021
Grade3.4
◀ Past 3.7● Present 2.8▶ Future 4.0
2 est.
The companyfiscal 2025, as filed
RevenueCN¥34.1M-61.0%
Net income-CN¥12.8M-899.0%
Earnings per shareCN¥-0.69-885.7%
Operating cash flow-CN¥6.4M-143.9%
CashCN¥36.7M+27928.9%
Debtn/a
Shareholders’ equityCN¥45.2M+729.4%
Shares, diluted18.5M+2.7%
Return on equity-28.4%
The recordfrom its filings
Filings in 202627
Newest filingNov 10 · EFFECT
Annual reportJan 30, 2026
Quarterly reportn/a
Next report due20-F by Jan 28
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Emerging growth company
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
232425
As filed, in CNY. Nothing here is a forecast.

News

Nov 10, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PASW · research, not advice